COVID-19 Health Messaging to Underserved Communities

NCT04371419 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14267

Last updated 2021-07-27

Study results available
· View outcomes & findings →

Summary

Recent data have shown that covid19 is disproportionately infecting and killing African Americans and Latinx people in the United States. The aim of the study is to determine which messages are most effective at increasing knowledge and changing behaviors that can protect individuals and their communities from the virus. To accomplish this aim, we plan to recruit approximately 20,000 Hispanic and African-American individuals and randomly assign them to videos that vary either the sender or the framing of the message, while providing the relevant public health information.

Conditions

  • Coronavirus

Interventions

BEHAVIORAL

Messaging

o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document. * Racial or ethnic identity of the doctor delivering the messages: concordant vs. discordant identity to the subject. * Whether the message includes an acknowledgment of "elephant in the room" issues for each target group: trust in the medical system or fear of deportation. * Whether the social distancing component of the message is delivered by Dr. Birx of the CDC or recorded by the MGH physicians. * Whether individuals are given information about how representative individuals perceive mask wearers of color. This information comes from results of our nationally representative pilot survey. * Some individuals in a control group will see messages later.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-13
Primary Completion
2020-05-24
Completion
2020-05-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04371419 on ClinicalTrials.gov